HPLC法测定大黄虫(庶虫)丸中大黄素和大黄酚的含量

目的建立高效液相色谱法测定大黄虫?丸中大黄素和大黄酚的含量。方法采用Supelcosil C18色谱柱(5μm,15 cm×4.6 mm);甲醇-0.1%(ω)磷酸(体积比83∶17)为流动相;流速为1 mL/m in;柱温为30℃;检测波长为254 nm。结果大黄素在0.0196~0.2352μg/mL范围内呈良好线性关系(r=0.9999);大黄酚在0.0424~1.060μg/mL范围内呈良好线性关系(r=0.9999);平均回收率大黄素为97.5%,RSD=1.48%,大黄酚为101.5%,RSD=1.57%。结论本法准确可靠,简便迅速,适用于测定大黄虫?丸中大黄素和大黄酚的含量。     

舒筋通络外用颗粒中大黄素和大黄酚的含量测定

目的:探讨舒筋通络外用颗粒主要成分大黄的含量测定方法.方法:用高效液相色谱法(HPLC法)测定大黄中大黄素、大黄酚的含量.结票:高效液相色谱法铡得大黄素、大黄酚含量之和为34.50～35.24mg/袋,线性范围分别为:大黄素:0.01～0.50 μg(r=0.9999),大黄酚0.025～1.25 μg(r=0.9999),平均加样回收率为100.4%,RSD=1.29%.结论:本方法简单、准确、专属性好,可用于舒筋通络外用颗粒中大黄素和大黄酚含量测定.     

高效液相色谱法测定槐黄丸中大黄素、大黄酚的含量

目的:建立高效液相色谱法测定槐黄丸中大黄素、大黄酚含量的方法。方法:色谱柱:Ultimate XB-C18柱(5μm,4.6 mm×250 mm);流速为1.0 mL/min;柱温:30℃;流动相:甲醇-0.1%磷酸溶液(85∶15);检测波长:254 nm;进样量:10μL。结果:大黄素在10.01～80.08μg/mL范围内呈良好的线性关系(r=0.9998),平均回收率(n=6)为99.3%(RSD=0.6%);大黄酚在10.06～80.48μg/mL范围内呈良好的线性关系(r=0.9997),平均回收率(n=6)为99.2%(RSD=0.7%)。结论:该方法简便、准确,专属性强,可作为槐黄丸的质量控制指标。     

HPLC法测定利胆片中大黄素和大黄酚

目的 HPLC法测定利胆片中大黄素及大黄酚。方法 Hypersil ODS色谱柱(250 mm×4.6 mm,5 μm);流动相甲醇-0.1％磷酸(78∶22);检测波长254 nm;体积流量0.8 mL/min;柱温40 ℃。结果 大黄素在0.98～15.72 μg /mL、大黄酚在1.56～37.34 μg/mL线性关系良好。大黄素平均回收率为99.767%,RSD为2.28%;大黄酚平均回收率为99.411% ,RSD为1.54%。结论 方法可行、重复性好,能有效控制利胆片的质量。     

HPLC法测定壮药铁包金中大黄素、大黄酚的含量

目的 建立高效液相色谱法测定壮药铁包金中大黄素、大黄酚的含量.方法 采用Diamonsil C18柱（250 mm×4.6 mm,5μm）色谱柱,流动相为甲醇-0.4％（体积分数）H3PO4（体积比75∶25）,流速为1.0mL/min,柱温为28℃,检测波长为254 nm.结果 铁包金中大黄素和大黄酚分别在1.4～ 14 μg/mL（r=0.999 6）和6～60 μg/mL（r=0.999 0）范围内线性关系良好,平均加样回收率分别为99.2％、95.8％,RSD值分别为2.0％、2.3％.结论 首次对铁包金药材中蒽醌类成分进行了含量测定,所建立的方法分离度高、方法学验证符合要求,可用于同时测定壮药铁包金中大黄素和大黄酚的质量分数.     

HPLC法测定清热润通胶囊中大黄素及大黄酚的含量

目的:测定清热润通胶囊中大黄素及大黄酚的含量。方法:采用高效液相法,色谱柱为YWGC18柱(250mm×4.6mm,5μm);甲醇-0.1%磷酸溶液(85∶15)为流动相;柱温25℃,检测波长为254nm,流速为1.0mL/min。结果:大黄素的线性范围为22.9μg～183.2μg,大黄酚的线性范围为20.1μg～160.8μg;平均加样回收率,大黄素为97.92%,RSD=1.75%(n=5),大黄酚为97.62%,RSD=1.18%(n=5)。结论:该方法简便、快速、准确,可用于清热润通胶囊的质量控制。     

HPLC法测定抗眩晕颗粒中大黄素和大黄酚

目的 应用HPLC法测定抗眩晕颗粒中大黄素和大黄酚。 方法 采用AGT C-18色谱柱(250 mm×4.6 mm,5 μm);流动相：甲醇0.1%磷酸(85∶15);检测波长：254 nm;体积流量：1.0 mL/min;柱温：25 ℃;进样量：20 μL。 结果 大黄素线性范围为0.036～2.400 μg/mL,r＝0.999 7,回收率为97.11%,RSD为1.11%;大黄酚线性范围为0.078～5.200 μg/mL,〗r＝0.999 8,回收率为98.77%,RSD为0.67%。结论 该方法用于测定抗眩晕颗粒中大黄素和大黄酚具有操作简便、结果准确、灵敏的特点,可用于该制剂的质量控制。     

HPLC法测定麻仁丸中厚朴酚、和厚朴酚、大黄素和大黄酚

目的:建立同时检测麻仁丸中厚朴酚、和厚朴酚、大黄素及大黄酚的测定方法。方法: 采用HPLC法。C18色谱柱;甲醇-0.1%磷酸水溶液为流动相,进行梯度洗脱;体积流量1.0 mL/min;检测波长254 nm。结果 根据回归方程,4种成分线性范围：和厚朴酚6.285～62.85 μg/mL,R 2=0.999 6;厚朴酚14.57～145.7 μg/mL,R2=0.999 6;大黄素2.744～27.44 μg/mL,R 2=0.9993;大黄酚6.828～68.28 μg/mL,R2=0.999 2;平均回收率：和厚朴酚98.8%,RSD为1.0%(n=6),厚朴酚99.9%,RSD为1.4%(n=6),大黄素98.9%,RSD为2.0%(n=6),大黄酚98.4%,RSD为1.6%(n=6)。结论:该方法操作简便、准确,重复性好,可用于麻仁丸的质量控制。     

RP-HPLC法同时测定虎杖中虎杖苷、白藜芦醇、大黄素和大黄素甲醚的含量

目的 建立同时测定虎杖中虎杖苷、白藜芦醇、大黄素和大黄素甲醚含量的分析方法 .方法 采用反相高效液相色谱法,以Diamonsil C18 (4.6 mm×250 mm,5 μm) 为色谱柱,乙腈和0.1%磷酸为流动相梯度洗脱,对10个产地虎杖样品中虎杖苷、白藜芦醇、大黄素和大黄素甲醚的含量同时进行了测定.检测波长305 nm,流速1.0 mL/min,柱温30℃.结果 虎杖苷、白藜芦醇、大黄素和大黄素甲醚分别在8.39～83.85 mg/L、3.36～33.6 mg/L、3.09～30.9 mg/L和2.15～21.5 mg/L浓度范围内符合线性关系,其平均回收率分别为100.8%[相对标准差(relative standard deviation,RSD) 1.3%]、99.3%(RSD 1.6%)、98.1%(RSD 1.5%)和92.2%(RSD 2.7%).不同产地虎杖中的虎杖苷、白藜芦醇、大黄素和大黄素甲醚含量有较大的差别.结论 本方法 准确、简便、重现性好,可用于虎杖中虎杖苷、白藜芦醇、大黄素和大黄素甲醚含量的同时测定.     

高效液相色谱法测定马兰中大黄酸、大黄素及大黄酚的含量

目的建立马兰药材中大黄酸、大黄素及大黄酚含量的测定方法。方法采用高效液相色谱法(highperformance liquid chromatography,HPLC)。色谱柱:Kromasil-C18柱(250mm×4.6mm,5μm);流动相:甲醇-0.1%磷酸水溶液;梯度洗脱;检测波长:254nm;流速:1ml/min;柱温:30℃。结果大黄酸、大黄素、大黄酚浓度分别在0.253～2.530μg/ml(r=0.999 6)、0.249～2.490μg/ml(r=0.999 3)、0.257～2.570μg/ml(r=0.999 7)范围内与峰面积呈良好的线性关系;平均加样回收率(n=6)分别为99.27%(RSD=1.28%)、99.78%(RSD=1.05%)、99.92%(RSD=0.83%)。结论所建立的方法准确、可靠、简便,适合马兰药材中大黄酸、大黄素及大黄酚含量的测定。     

Value of D-Dimers in patients with acute aortic dissection

Objective: To evaluatel the value of D-dimers in patients with acute aortic dissection (AAD). Methods: This study consisted of 16 patients with AAD and 27 non-AAD patients. Serum D-dimets were measured by Sta-Liatest D-DI immunoturbidimetric assay. Results: D-dimer level was higher (P ＜ 0.001) in patients with AAD(7.91 ± 5.52 μg/ml) than that in non- AAD group(1.57±1.24 μg/ml). D-dimer was positive (＞0.4 μg/ml) in all patients with AAD and in 10 control group patients (37%). Among patients with acute AAD, D-dimers tended to be higher in Stanford A than in Stanford B (8.67 ± 4.31 μg/ml vs. 3.24±1.27 μg/ml, P ＜0.01). D-dimer values tended to be higher in more extended disease(3.84 ± 1.65 μg/ml, 8.57 ± 3.58 μg/ml and 11.87 ± 5.69 μg/ml in thoracic aorta, thoracic and abdominal aorta, thoracic and abdominal aorta and iliacal arteries, respectively, P ＜ 0.05 for both 8.57 ± 3.58 and 11.87 ± 5.69 vs. 3.84 ± 1.65 ). Including the control group into the analysis, we found a sensitivity of 100%, a negative predictive value of 100%, and a specificity of 66% and a positive predictive value of 64% for D-dimer in diagnosis of AAD in our patients with suspected AAD. Conclusion: D-dimer was elevated in patients with AAD. A negative D-dimer test result could be useful in excluding AAD.     

Research of combined liver-kidney transplantation model in rats

Objective： To set up a simple and reliable rat model of combined liver-kidney transplantation. Methods： SD rats served as both donors and recipients. 4℃ sodium lactate Ringer＇s was infused from portal veins to donated livers,and from abdominal aorta to donated kidneys, respectively. Anastomosis of the portal vein and the inferior vena cava （IVC） inferior to the right kidney between the graft and the recipient was performed by a double cuff method, then the superior hepatic vena cava with suture. A patch of donated renal artery was anastomosed to the recipient abdominal aorta. The urethra and bile duct were reconstructed with a simple inside bracket. Results： Among 65 cases of combined liver-kidney transplantation, the success rate in the late 40 cases was 77.5%. The function of the grafted liver and kidney remained normal. Conclusion： This rat model of combined liver-kidney transplantation can be established in common laboratory conditions with high success rate and meet the needs of renal transplantation experiment.     

APPLICATION OF LORNOXICAM TO PATIENT-CONTROLLED ANALGESIA IN PATIENTS UNDERGOING ABDOMINAL SURGERIES

FOR anesthesiologis s ,treatingpostoperativepainhas alwaysbeen a problem.Althoughopioidshave been provedtobe effective,theirsideeffectscouldnotbeignored.With thedevelopmentofscienceand pharmacology,many drugs with aspectsof satisfactoryanalgesicefficacyand couldbe welltoleratedby patientshave been developed.And lornoxicamisone of them, which isa non-steroidalanti-inflammatorydrug (NSAID ), with analgesic, anti-infl-ammatory,andantipyreticproperties.Itseliminationhalf-time(3 to 5 hours) isle…     

安心颗粒对急诊经皮冠状动脉介入术后生活质量影响的研究

目的：评价使用安心颗粒对急诊经皮冠状动脉介入术（PPCI）术后生活质量的影响.方法：将160例接受PPCI的急性ST段抬高型心肌梗死患者随机分为安心颗粒组（术前顿服安心颗粒8.8g,术后安心颗粒4.4 g/次,每日2次）和对照组（仅接受基础药物治疗）.所有患者均服用阿司匹林、氯吡格雷和阿托伐他汀.分别在入院时、出院前1d、出院后180 d时,应用心肌梗死多维度量表（MIDAS）、中文版SF-36评价量表对患者生活质量评分.并观察术后30 d以内的出血并发症、血小板减少症发生情况.结果：入院时和出院前1d,两组患者的心肌梗死MIDAS、SF-36量表评分比较无差异（P＞0.05）;出院后180 d时,与对照组比较,安心颗粒组MIDAS、SF-36评分明显减低（P＜0.05）;组内与入院时比较,两组出院前1d、出院后180 d时,MIDAS、SF-36评分均降低（P＜0.05）.两组患者在随访期间均无大量出血、少量出血、重度和极重度血小板减少症发生,安心颗粒组有4例、对照组有7例发生不明显出血（P＞0.05）.两组发生轻度血小板减少症的患者数比较无差异（P＞0.05）.结论：PPCI使用安心颗粒,能改善急性ST段抬高型心肌梗死患者的生活质量,且不增加出血风险.     

The comparative studies of the influences of Urapidil and Nicardipine on sino-atrial node function, atrio-ventricular node function and hemodynamics

Objective:To investigate the influences of urapidil and nicardipine on rabbit sinus function,atrio-ventricular node function and hemodynamics.Methods:Thirty-two Angora's rabbits were selected and randomly divided into four groups.U1 group:urapidil 0.25 mg/kg;U2 group:urapidil 0.5 mg/kg;N1 group:nicardipine 10 μg/kg;N2 group:nicardipine 20 μg/kg.All these medicine were administrated within 30 seconds.Measurements were taken before and after the administration of urapidil or nicardipine for the following data:mean blood pressure(MAP),heart rate(HR),sino-atrial conduction time(SACT),maximal sinoatrial recovery time(SNRTmax)corrected sinus node recovery time(CSNRT),index of sinus node recovery time(SNRTI),Wenckebach A-V conduction frequency (WB),and P-R interval.Results:Significant MAP and HR changes were identified in all of the four groups before and after administration of both urapidil and nicardipine.No significant changes could be found in the rest of the parameters.Intergroup analysis showed that SACT and CSNRT of N1 and N2 groups were shorter than those of the U2 group(P＜0.01);the MAP decreased(P＜0.01)and the HR increased drastically(P＜0.01).Conclusions:Neither urapidil(0.25 mg/kg,0.5 mg/kg)nor nicardipine(10μg/kg,20μg/kg)has any significant influence on rabbit sinus function or rabbit atrio-ventricular node function.Nicardipine could be a better choice than urapidil for parafunctional sinus node patients.     

Expression of OPGmRNA and ODFmRNA in the patients of hip fracture due to osteoporosis

Objective：To investigate the gene expression of osteoprotegerin（OPG） and osteoclast differentiation factor（ODF） in the bone tissue of patients with hip fracture due to osteoporosis. Methods：OPGmRNA and ODFmRNA in the bone tissue in 50 cases of osteoporosis sufferers（over 50 years old） with hip fracture（Observer Group） and 30 cases of hip facture sufferers with no osteoporosis（Control group） were analyzed with the Semi-Quantitative RT-PCR method. Results：The mRNA expressed of ODF, OPG were both high in the patients with hip fracture. In the control group, the expression of OPG mRNA was observed, while the expression of ODF mRNA was very slight. Conclusion：Aged patients contained all signals including OPG, ODF that are essential for inducing osteoclastogenesis and promoting bone resorption.     

The clinicopathological and immuohistochemical analysis of solid-pseudopapillary tumor of the pancreas： report of 9 cases

Objective：To investigate the clinical features, pathological characteristics and immunophenotype of solid-pseudopapillary tumor of the pancreas（SPTP）. Methods：Nine surgically treated cases of SPTP were retrospectively reviewed. Hematoxylin and Eosin（HE） staining and immunohistochemical staining were used to analyze all cases, and the general clinical data was collected. Results：Six patients were asymptomatic except for a palpable mass. Two patients complained of vague-epigastric pain. One patient appeared jaundice. The tumor was encapsulated and solid tissues alternately with cystic tissues. Histologically, the histological structure of solid portion was pseudopapillary with a fibrovascular core. Tumor cells were uniform and medium-sized which were arranged in sheets ets or nests or pseudopapillary patterns. Immunohistochemical studies demonstrated that SPTP proved positive in vimentin（9/9 cases）, AAT（9/9 cases）, NSE（9/9 cases）, ACT（7/9 cases）, CK20（2/9 cases）, CgA（1/9 cases）, S-100（3/gcases）, PR（4/gcases）, Syn（3/9 cases） and CD56（5/9cases）, negative in CEA and ER. Conclusion：SPTP is a tumor predominantly occurring in young women frequently without special symptoms. This tumor has various characteristical histological patterns with different immunophenotype.     

Acupuncture Combined with Spinal Tui Na for Treatment of Primary Dysmenorrhea in 30 Cases

Objective: To observe the therapeutic effects in acupunture treatment of primary dysmenorrhea combined with spinal Tui Na, and study its mechanism. Methods: Thirty cases of the treatment group were treated by acupuncture combined with spinal Tui Na, and thirty cases in the control group were treated by routine acupuncture. Results: The total effective rate was 93.3% in the treatment group, and 73.3% in the control group, with a significant difference between the two groups (P<0.05). Conclusions: Acupuncture combined with spinal Tui Na has good prospects for treatment of primary dysmenorrhea.     

Luo Lingjie's Experience in Treating Chronic Nephropathy

In treating chronic nephropathy,Luo Lingjie,a chief physician,pays attention to regulating the balance between yin and yang,treating infection if present,and removing pathogenic factors.He prescribes gentle drugs and uses carefully strongly warming-tonifying ones,emphasizes the importance of persuading the patient to persist in treatment with medication and nurse one's health for recuperation,and is good at combined use of TCM and western medicine therapy and brings the merits of various therapies into full play,with obvious theraoeutic effects.     

Dr.Zhang Ren's Experience in the Acupuncture Treatment of Different Diseases with the Same Therapeutic Principle

Dr.Zhang Ren,the chief physician,is the chairman of Shanghai Acupuncture and Moxibustion Association.Having been engaged in medicine for about 40 years,he is experienced in treating various intractable diseases.In his long years of clinical practice,he advocates taking the TCM differentiation as the basis to seek for the acupuncture method for treatment of modern intractable diseases.The author of this essay had the fortune to follow Dr.Zhang in study.The following is a summary of Dr.Zhang's experience in the acupuncture treatment for different intractable diseases with the same therapeutic principle.